Supporting clinical teams

The latest vascular access & infusion therapy evidence, made easy for clinical teams.

IVTEAM is a global resource bringing healthcare professionals daily updates on the most relevant vascular access and infusion therapy evidence — free to read, wherever you work.

PICC placement in patients with newly diagnosed acute leukemia – Full Text

“The primary objective of this single-center retrospective study (November 2023-August 2024; Ruijin Hospital) was to evaluate the feasibility and safety of a peripherally inserted central catheter (PICC) puncture and nursing protocol incorporating ultrasound-guided Seldinger puncture, controlled sheath withdrawal with gauze-assisted compression, and localized hemostatic dressing in 101 patients prior to chemotherapy” Wei et al (2026).

Read More »

Management of chemoport-related complications

“Chemoport insertion is a safe and effective method for long-term chemotherapy administration when performed using appropriate technique and vigilance. Awareness, early recognition, and prompt management of complications are essential to minimize morbidity” Mohan et al (2026).

Read More »

OPAT in long-term care facilities

“OPAT may be a safe and feasible alternative to hospitalization in selected frail institutionalized older adults, allowing treatment of complex infections outside the hospital setting. Optimization of antimicrobial stewardship and vascular access strategies remains important in this population” Licetti et al (2026).

Read More »

Prevention of catheter-related thrombosis study

“A single infusion of amrecibart or cenvacibart reduced the incidence of venous thromboembolism following PICC insertion, suggesting FXI inhibition at the A2 or catalytic domain as a promising prophylactic strategy for contact-mediated thrombosis” Zwicker et al (2026).

Read More »

Pain reduction during intravenous cannulation

“Pain intensity declined substantially over time in all groups. In the primary analysis, Diclofenac and EMLA were associated with lower early pain intensity than Piroxicam, although some pairwise findings were sensitive to the analytical approach” Amini et al (2026).

Read More »

Severe consequence of unnecessary retention of a TIVAD

“Leaving an inactive device for 12 months post-treatment represents a significant risk. Furthermore, a false-negative initial ultrasound led to a critical diagnostic delay, underscoring that strong clinical suspicion should sometimes override early negative imaging to prevent progression from deep vein thrombosis to PCD” Delorme et al (2026).

Read More »

Chlorhexidine gluconate significantly reduces CLABSI

“CHG intervention can significantly reduce the risk of CLABSI, and the protective effect varies by intervention type: catheter coating/impregnation interventions have the strongest protective effect, dressing interventions have a moderate protective effect, while daily bathing showed no significant effect” Zhang et al (2026).

Read More »

OPAT in infants aged under 1 year

“Our findings suggest OPAT decisions for infants aged under 1 year should also incorporate factors such as duration of therapy and underlying conditions, rather than age alone, to help reduce the risk of OPAT” Beauchamp-Walters et al (2026).

Read More »